Designed Cyclic Permutants of HIV-1 gp120: Implications for Envelope Trimer Structure and Immunogen Design

被引:18
|
作者
Saha, Piyali [1 ]
Bhattacharyya, Sanchari [1 ]
Kesavardhana, Sannula [1 ]
Miranda, Edward Roshan [1 ]
Ali, P. Shaik Syed [1 ]
Sharma, Deepak [1 ]
Varadarajan, Raghavan [1 ]
机构
[1] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; COLONY-STIMULATING FACTOR; NEUTRALIZING ANTIBODIES; CIRCULAR PERMUTATION; GLYCOPROTEIN TRIMERS; CRYSTAL-STRUCTURES; DISULFIDE BONDS; LIGAND-BINDING; VACCINE DESIGN; CD4; RECEPTOR;
D O I
10.1021/bi300003v
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Most HIV-1 broadly neutralizing antibodies are directed against the gp120 subunit of the env surface protein. Native env consists of a trimer of gp120-gp41 heterodimers, and in contrast to monomeric gp120, preferentially binds CD4 binding site (CD4bs)-directed neutralizing antibodies over non-neutralizing ones. Some cryo-electron tomography studies have suggested that the V1V2 loop regions of gp120 are located close to the trimer interface. We have therefore designed cyclically permuted variants of gp120 with and without the h-CMP and SUMO2a trimerization domains inserted into the V1V2 loop. h-CMP-V1cyc is one such variant in which residues 153 and 142 are the N- and C-terminal residues, respectively, of cyclically permuted gp120 and h-CMP is fused to the N-terminus. This molecule forms a trimer under native conditions and binds CD4 and the neutralizing CD4bs antibodies b12 with significantly higher affinity than wild-type gp120. It binds non-neutralizing CD4bs antibody F105 with lower affinity than gp120. A similar derivative, h-CMP-V1cycl, bound the V1V2 loop-directed broadly neutralizing antibodies PG9 and PG16 with similar to 20-fold higher affinity than wild-type JRCSF gp120. These cyclic permutants of gp120 are properly folded and are potential immunogens. The data also support env models in which the V1V2 loops are proximal to the trimer interface.
引用
收藏
页码:1836 / 1847
页数:12
相关论文
共 50 条
  • [1] Stabilization of Outer Domain of gp120 from HIV-1 Subtype C for Vaccine Immunogen Design
    Thompson, Jesse
    Kumar, Pankaj
    Yi, Jizu
    Bowder, Dane
    Wood, Charles
    Xiang, Shi-Hua
    PROCEDIA OF THE 8TH VACCINE & ISV CONGRESS, 2015, 9 : 6 - 15
  • [2] Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120
    Lekkerkerker, AN
    Ludwig, IS
    van Vliet, SJ
    van Kooyk, Y
    Geijtenbeek, TBH
    VIROLOGY, 2004, 329 (02) : 465 - 476
  • [3] Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake
    Sun, Lina
    Ishihara, Mayumi
    Middleton, Dustin R.
    Tiemeyer, Michael
    Avci, Fikri Y.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (39) : 15178 - 15194
  • [4] GP120: Target for neutralizing HIV-1 antibodies
    Pantophlet, Ralph
    Burton, Dennis R.
    ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 739 - 769
  • [5] Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility
    Pancera, Marie
    Majeed, Shahzad
    Ban, Yih-En Andrew
    Chen, Lei
    Huang, Chih-chin
    Kong, Leopold
    Kwon, Young Do
    Stuckey, Jonathan
    Zhou, Tongqing
    Robinson, James E.
    Schief, William R.
    Sodroski, Joseph
    Wyatt, Richard
    Kwong, Peter D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (03) : 1166 - 1171
  • [6] Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
    Kong, Leopold
    Lee, Jeong Hyun
    Doores, Katie J.
    Murin, Charles D.
    Julien, Jean-Philippe
    McBride, Ryan
    Liu, Yan
    Marozsan, Andre
    Cupo, Albert
    Klasse, Per-Johan
    Hoffenberg, Simon
    Caulfield, Michael
    King, C. Richter
    Hua, Yuanzi
    Le, Khoa M.
    Khayat, Reza
    Deller, Marc C.
    Clayton, Thomas
    Tien, Henry
    Feizi, Ten
    Sanders, Rogier W.
    Paulson, James C.
    Moore, John P.
    Stanfield, Robyn L.
    Burton, Dennis R.
    Ward, Andrew B.
    Wilson, Ian A.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2013, 20 (07) : 796 - +
  • [7] Non-natural Peptide Triazole Antagonists of HIV-1 Envelope gp120
    Kamanna, Kantharaju
    Aneja, Rachna
    Duffy, Caitlin
    Kubinski, Pamela
    Moreira, Diogo Rodrigo
    Bailey, Lauren D.
    McFadden, Karyn
    Schoen, Arne
    Holmes, Andrew
    Tuzer, Ferit
    Contarino, Mark
    Freire, Ernesto
    Chaiken, Irwin M.
    CHEMMEDCHEM, 2013, 8 (02) : 322 - 328
  • [8] Tryptophan 375 stabilizes the outer-domain core of gp120 for HIV vaccine immunogen design
    Hu, Duoyi
    Bowder, Dane
    Wei, Wenzhong
    Thompson, Jesse
    Wilson, Mark A.
    Xiang, Shi-Hua
    VACCINE, 2017, 35 (23) : 3067 - 3075
  • [9] Molecular modeling study of HIV-1 gp120 attachment inhibitors
    Gadhe, Changdev G.
    Kothandan, Gugan
    Madhavan, Thirumurthy
    Cho, Seung Joo
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (08) : 1892 - 1904
  • [10] Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet
    Schiavone, Marco
    Fiume, Giuseppe
    Caivano, Antonella
    de Laurentiis, Annamaria
    Falcone, Cristina
    Masci, Francesca Fasanella
    Iaccino, Enrico
    Mimmi, Selena
    Palmieri, Camillo
    Pisano, Antonio
    Pontoriero, Marilena
    Rossi, Annalisa
    Scialdone, Annarita
    Vecchio, Eleonora
    Andreozzi, Concetta
    Trovato, Maria
    Rafay, Jan
    Ferko, Boris
    Montefiori, David
    Lombardi, Angela
    Morsica, Giulia
    Poli, Guido
    Quinto, Ileana
    Pavone, Vincenzo
    de Berardinis, Piergiuseppe
    Scala, Giuseppe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (05): : 5674 - 5699